Medarex preclinical data

MDX-1338 reduced tumor growth in animal models of Burkitt's lymphoma and refractory acute myelogenous leukemia (AML). MDX-1338 is a human antibody against CXC chemokine receptor 4 ( CXCR4, NPY3R). D...